The measurement of parathyrin (parathyroid hormone; PTH), an 84-amino-acid peptide produced by the parathyroid glands, is a useful tool in the diagnosis of calcium disorders.3 The main function of PTH is to control the concentration of calcium in extracellular fluids, with the excretion of PTH increasing as the calcium concentrations decrease (1,2). Normal concentrations of intact PTH in plasma range from -1 to 5 pmol/L, with both the increased (1 2). Several methods for monitoring only intact were recently reported, based on two-site immunometri assays (7) (8) (9) . In these assays two sets of antibodies used: one set is immobilized onto a solid support an
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used to bind one end of intact PTH, such as its 1-34 N-terminal region; the second set is labeled and used to identify the presence of PTH by binding to a second domain, such as the 44-68 midmolecule region. Given this combination, only intact FF11 will react with both sets of antibodies and be detected (7) (8) (9) . Routine monitoring of intact PTH is best done with a method that is not only sensitive but also fast and fully automatable. However, current intact PTH assays are manual methods that take a long time to perform (i.e., typically 24 h). To overcome these problems, we (10) recently developed components and excess labeled antibodies are washed from the column, a low pH buffer is applied to elute intact P'FH and its associated labeled antibodies from the column. As these compounds are eluted, they are combined on-line with an alkaline peroxide postcolumn reagent; the resulting production rf light from the acridinium ester label is measured with a flow-through detector. The column is then regenerated, and the next sample is injected (10).
In a previous report we described the design and eptimization of this system for PT!! determinations 10). Here we examined the performance and utility of this method in a routine clinical setting we considered the response, precision, and accuracy of the method and the effects of potential interferences, such as circulating PT!! fragments.
We were from Micrornembranes, Inc. (Newark, NJ). All solutions were prepared with water from a Milli-Q Water System (Millipore, Bedford, MA).
Instrumentation
The chrornatographic system was the same as doscribed before (10). We used a Hitachi (Tokyo, Japan) L-6200 ternary pump for mixing and pumping postcolumn reagent and two Hitachi L-6000 isocratic pumps for delivering the application and elution buffers to the The manual ICMA assay used in the correlation studies was performed as described previously (9 Retained PT!! and associated labeled antibodies were detected as they eluted from the column by combining the column eluent with a postcolumn reagent containing, per liter, 10 mL of Triton X-100, 0.75 mol of sodium hydroxide, and 0.43 mmol of hydrogen peroxide. This reagent was prepared on-line, as described previously (10), and was applied to the system at a flow-rate of 1.0 mL/min. The post-column reagent and column eluent were combined by using a standard miring tee from Upchurch. The mixture was then immediately passed through the flow cell of the on-line chemilumineacence detector, and the light produced by the acridinium ester label was monitored. 
Subjects

Results
Assay Performance
The carryover of the HPIAC/CL system was <0.16%, as determined by mi'king several alternate injections of 1000 and 0 pmoliL FFH plasma standards.
On the basis of these carryover studies and previous work, we developed the event schedule given in Materials was determined as 0.2 pmol/L for peak-area measurements and 0.5 pmol/L for peak-height measurements. These limits of detection reflect the concentration of injected FF1! required to produce a signal 2 SD above the signal produced by the zero standard and agree with previous data obtained with this system (10).
As shown in Figure 1 , the linear range (i.e., the range of concentrations within ± 5% of the best-fit line) extended up to 38 pmol/L for the peak-height measurements. For peak-area measurements, the same standards demonstrated a linear range extending to 44 pmol/L. Thus, the peak-height and peak-area calibration curves had linear ranges for concentrations covering 1.8 and 2.3 orders of magnitude, respectively. These results also agree with earlier work on this system (10) and are similar to linear ranges seen for manual PTH assays. The dynamic range (i.e., the range of concentrations producing any detectable change, linear or nonlinear, in the response) extended up to at least 250 pmol/L, with no apparent hook effect. Analytical recovery of intact PTH in the HPIAC/CL system was determined by analyzing normal plasma samples supplemented with various amounts of exogenous intact PTH. As Table 1 illustrates, all samples showed a high degree of recovery, with values ranging from 93% to 102% (mean 97%). (Table 2) . For the first sample, the average relative error was only -0.6% (range -2.6% to + 1.6%); for the other sample, the average relative error was +1.0% (range -4.1% to +8.2%).
The within-day precision of the automated FF1! assay was measured by making 20 sequential injections of plasma samples with either normal or abnormal concentrations of FF1! (4.2 and 30 pmolJL, respectively).
The within-day precisions (CVs) for these samples were ± 9.2% and ± 5.6%, respectively. The day-to-day precision of the system was determined by injecting the same samples over the course of 10 d. The day-to-day precision was ± 10.3% for the normal samples and ± 5.7% for the abnormal samples. All of these results are similar to those obtained with equivalent manual FFH immunemetric assays (7, 8 though some random variation was noted between the individual calibration curves, linear regression of the slopes and intercepts indicated no significant change (<6%) in the curves over the course of this study, whether based on peak heights or peak areas. From this we concluded that the stability of the immobilized antibody was not a mnjor factor in limiting the column life.
One important factor affecting column life was a buildup in pressure after a large number of plasma samples were injected. To determine the correlation of the HPIAC/CL system with a manual intact PTH assay, we used both procedures to analyze a series of 130 patients' samples in which intact FF1! concentrations ranged from 0.5 to 42 pmol/L. The best-fit line between the results of the two assays ( Figure 2 ) had a slope (±2 SD) of 0.99 ± 0.04 and an intercept of 0.70 ± 0.6 pmol'L; the correlation coefficient was 0.97. Figure  3 FFH results for patients with chronic renal failure are also shown in Figure 3 . As reported by others, samples from these patients exhibit a wide range of PTH concentrations (9). In our hands, these concentrations ranged 
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